Prelude Therapeutics (PRLD.BOATS) Q4 2025 Earnings

12NovConfirmed
Q4 2025
-0.37
-0.33
-0.3
-0.26

Details

Expected EPS
-0.37
Actual EPS
-0.26
Surprise EPS
0.11
Surprise Percent
+29.73%

Description

Prelude Therapeutics (PRLD.BOATS) has reported earnings of -0.26 per share for Q4 2025.

0 Comments

Share your thoughts